0RGI vs JAZZ: Side-by-Side Comparison
Compare COSMO Pharmaceuticals SA (0RGI) and Jazz Pharmaceuticals plc (JAZZ) side by side: valuation, financials, growth and model signals on Bullrun.
| Metric | 0RGI | JAZZ |
|---|---|---|
| Company | COSMO Pharmaceuticals SA | Jazz Pharmaceuticals plc |
| Country / Exchange | Ireland · LSE | Ireland · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Biotechnology |
| Market cap | — | USD 15.28B |
| P/E ratio | 50.2 | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (FY2025) | GBP 104.17M | USD 4.27B |
| Revenue growth YoY | -61.0% | +4.9% |
| Net income | GBP -3.61M | USD -356.15M |
| Gross margin | 48.5% | — |
| Diluted EPS | — | -5.84 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.